secwatch.observer — SEC 8-K summary
======================================

Issuer:     CERO THERAPEUTICS HOLDINGS, INC. (CERO)
CIK:        0001870404
Form:       8-K
Filed at:   2026-07-17T20:37:57+00:00
Accession:  0001213900-26-079207
Event type: debt
Sentiment:  neutral
Materiality: 0.55
Item codes: 1.01, 2.03, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CERo Therapeutics enters into $2.085M convertible promissory note with SRX Global
--------------------------------------------------------------------------------

- Maximum loan amount $2,085,200; $750,000 funded May 23, $663,600 June 23, $671,600 July 14, 2026.
- Note bears 10% interest per annum, matures May 28, 2027.
- Convertible at lesser of $0.05 or 80% of avg of 5 lowest intraday prices in prior 20 days; 4.99% ownership cap.
- Company must file registration statement for resale of shares issuable upon conversion.
- Issuance exempt under Section 4(a)(2) and Rule 506(b); Lender is accredited investor.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1870404/000121390026079207/0001213900-26-079207-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1870404/000121390026079207/ea0298463-8k_cero.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-079207

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer